Insulin-like growth factor-binding protein-2 (IGFBP-2) concentrations are low in subjects with metabolic syndrome and type 2 diabetes. Intriguingly, recent studies have demonstrated an association between high IGFBP-2 concentrations and increased mortality not only in populations with certain types of cancer, but also in relatively healthy populations. We evaluated the role of IGFBP-2 in relation to BMI and mortality.
Design and Participants
BMI, insulin sensitivity, insulin-like growth factor 1 (IGF-I) and IGFBP-2 were assessed repeatedly in 539 participants of the Baltimore Longitudinal Study of Aging around the ages of 55, 65 and 75 years.
IGFBP-2 concentrations positively correlated with insulin sensitivity and inversely with BMI, both at baseline and follow-up. Independent of IGF-I, sex, BMI and insulin sensitivity, circulating IGFBP-2 levels positively correlated with age (P < 0.001). Changes over time in BMI were associated with an inverse correlation in IGFBP-2 concentrations. Furthermore, we found indications of a relationship between low baseline IGFBP-2 levels and mortality. Remarkably, after adjustment for insulin sensitivity, the opposite association was found, as a unit increase of log(IGFBP2) was associated with an increase in the log hazard by 1.43 (95% CI: 0.3–2.6). This accounted for both baseline (P = 0.02) as well as serial (P < 0.001) measurements of IGFBP2. Finally, in this longitudinal study, we found that IGF-I concentrations increased with age (0.82 ± 0.2 (µg/L)/year, P < 0.001).
This is the first study investigating the relationship between IGFBP-2 levels and age in a longitudinal setting. Serum IGFBP-2 levels increase with age after the age of 50 years and evolve in parallel with insulin sensitivity. IGFBP-2 may therefore be a potential marker for insulin sensitivity. We further show that IGFBP-2 levels can predict mortality in this aging population. However, its predictive value for mortality can only be interpreted in relation to insulin sensitivity. After adjustment for insulin sensitivity, high IGFBP-2 levels are predictive of increased mortality.
BorstSEMillardWJLowenthalDT.Growth hormone, exercise, and aging: the future of therapy for the frail elderly. Journal of the American Geriatrics Society199442528–535. (https://doi.org/10.1111/j.1532-5415.1994.tb04976.x)
WheatcroftSBKearneyMTShahAMEzzatVAMiellJRModoMWilliamsSCCawthornWPMedina-GomezGVidal-PuigAet al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes200756285–294. (https://doi.org/10.2337/db06-0436)
FrystykJSkjaerbaekCVestboEFiskerSOrskovH.Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes/Metabolism Research and Reviews199915314–322. (https://doi.org/10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E)
HealdAHKaushalKSiddalsKWRudenskiASAndersonSGGibsonJM.Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Experimental and Clinical Endocrinology and Diabetes2006114371–376. (https://doi.org/10.1055/s-2006-924320)
van den BeldAWBlumWFBrugtsMPJanssenJAGrobbeeDELambertsSW.High IGFBP2 levels are not only associated with a better metabolic risk profile but also with increased mortality in elderly men. European Journal of Endocrinology2012167111–117. (https://doi.org/10.1530/EJE-12-0160)
FazeliPKLawsonEAPrabhakaranRMillerKKDonohoDAClemmonsDRHerzogDBMisraMKlibanskiA.Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism2010954889–4897. (https://doi.org/10.1210/jc.2010-0493)
LiouJMShunCTLiangJTChiuHMChenMJChenCCWangHPWuMSLinJT.Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. Journal of Clinical Endocrinology and Metabolism2010951717–1725. (https://doi.org/10.1210/jc.2009-2668)
Baron-HaySBoyleFFerrierAScottC.Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clinical Cancer Research2004101796–1806. (https://doi.org/10.1158/1078-0432.CCR-0672-2)
Probst-HenschNMSteinerJHSchramlPVargaZZurrer-HardiUStorzMKorolDFehrMKFinkDPestalozziBCet al. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research2010161025–1032. (https://doi.org/10.1158/1078-0432.CCR-09-0957)
HuDPawlikowskaLKanayaAHsuehWCColbertLNewmanABSatterfieldSRosenCCummingsSRHarrisTBet al. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study. Journal of the American Geriatrics Society2009571213–1218. (https://doi.org/10.1111/j.1532-5415.2009.02318.x)
ShockNWGreulichRCCostaPTJrAndresRLakattaEGArenbergDTobinJD. Normal Human Aging. Washington D.C.: U.S. Govt. Printing office (1984 edn.). the Baltimore longitudinal Study of aging 84–2450 Ed NIo Health.
MatsudaMDeFronzoRA.Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care1999221462–1470. (https://doi.org/10.2337/diacare.22.9.1462)
LiZMiardSLaplanteMSonenbergNPicardF.Insulin stimulates IGFBP-2 expression in 3T3-L1 adipocytes through the PI3K/mTOR pathway. Molecular and Cellular Endocrinology201235863–68. (https://doi.org/10.1016/j.mce.2012.02.022)
AsilmazECohenPMiyazakiMDobrzynPUekiKFayzikhodjaevaGSoukasAAKahnCRNtambiJMSocciNDet al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. Journal of Clinical Investigation2004113414–424. (https://doi.org/10.1172/JCI200419511)
YauSWHenryBARussoVCMcConellGKClarkeIJWertherGASabinMA.Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models. Endocrinology20141552133–2143. (https://doi.org/10.1210/en.2013-2099)
YoungNJMetcalfeCGunnellDRowlandsMALaneJAGilbertRAveryKNDavisMNealDEHamdyFCet al. A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, And IGFBP-3 in men in the United Kingdom. Cancer Causes and Control201223907–917. (https://doi.org/10.1007/s10552-012-9961-6)
Closa-MonasteroloRFerreNLuqueVZaragoza-JordanaMGroteVWeberMKoletzkoBSochaPGruszfeldDJanasRet al. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011941920S–1927S. (https://doi.org/10.3945/ajcn.110.001123)
MattssonASvenssonDSchuettBOsterzielKJRankeMB.Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Growth Hormone and IGF Research200818506–516. (https://doi.org/10.1016/j.ghir.2008.04.005)
van den BeldAWBlumWFPolsHAGrobbeeDELambertsSW.Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. European Journal of Endocrinology2003148627–634. (https://doi.org/10.1530/eje.0.1480627)
XiGSolumMAWaiCMaileLARosenCJClemmonsDR.The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice. Endocrinology20131544146–4157. (https://doi.org/10.1210/en.2013-1236)
CountsDRGwirtsmanHCarlssonLMLesemMCutlerGBJr.The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. Journal of Clinical Endocrinology and Metabolism199275762–767.
SandersJLGuoWO’MearaESKaplanRCPollakMNBartzTMNewmanABFriedLPCappolaAR.Trajectories of IGF-I predict mortality in older adults: the cardiovascular Health Study. Journals of Gerontology: Series A Biological Sciences and Medical Sciences201873953–959. (https://doi.org/10.1093/gerona/glx143)
BannDHollyJMPLashenHHardyRAdamsJKuhDOngKKBen-ShlomoY.Changes in insulin-like growth factor-I and -II associated with fat but not lean mass in early old age. Obesity201523692–698. (https://doi.org/10.1002/oby.21002)
KaplanRCBuzkovaPCappolaARStricklerHDMcGinnAPMercerLDArnoldAMPollakMNNewmanAB.Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study. Journal of Clinical Endocrinology and Metabolism2012971970–1976. (https://doi.org/10.1210/jc.2011-2967)